• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能的针对不同基因设计的药物发现与设计

AI-Based Drug Discovery and Design for Different Genetic Designs.

作者信息

Basumatary Devi, Devi Shalini G, Swargiary Deepsikha, Borah Jagat C

机构信息

Chemical Biology Lab-I, Institute of Advanced Study in Science and Technology (IASST), Guwahati, Assam, India.

Department of Biotechnology, Guwahati University, Guwahati, Assam, India.

出版信息

Methods Mol Biol. 2025;2952:125-148. doi: 10.1007/978-1-0716-4690-8_8.

DOI:10.1007/978-1-0716-4690-8_8
PMID:40553331
Abstract

Personalized medicine, also known as precision medicine, is a branch of medicine that considers each patient's unique genetic makeup, lifestyle, and environment to customize treatment plans, preventative measures, and diagnoses. By tailoring medical interventions to individual genetic profiles, personalized medicine maximizes treatment efficacy. Better health outcomes and less trial-and-error in therapy selection result from this method, which guarantees that patients receive medicines that are most likely to work for them. Artificial intelligence-based drug discovery and design is an innovative approach that leverages artificial intelligence (AI) techniques to develop personalized medicines tailored to individual genetic profiles. AI holds immense promise in revolutionizing personalized medicine by harnessing the power of data-driven insights to optimize healthcare delivery, improve patient outcomes, and advance our understanding of disease mechanisms and treatment strategies. AI-based algorithms can be optimized to analyze large-scale, diversified datasets, including genetic information and by integrating and examining numerous data sources, AI can find patterns, correlations, and insights that conventional analytic techniques would miss. AI algorithms are used to interpret complex genomic data, such as DNA sequencing results, to identify genetic variants associated with disease susceptibility, drug response, and treatment outcomes. This chapter aims to analyze the present state of AI-based drug development for various genetic designs, along with the accompanying issues and measures to fully utilize the potential AI holds in personalized medicine.

摘要

个性化医疗,也被称为精准医疗,是医学的一个分支,它考虑每个患者独特的基因构成、生活方式和环境,以定制治疗方案、预防措施和诊断。通过根据个体基因特征定制医疗干预措施,个性化医疗可使治疗效果最大化。这种方法能带来更好的健康结果,减少治疗选择中的反复试验,确保患者获得最有可能对其有效的药物。基于人工智能的药物发现与设计是一种创新方法,它利用人工智能(AI)技术开发针对个体基因特征的个性化药物。人工智能通过利用数据驱动的见解来优化医疗服务、改善患者预后,并增进我们对疾病机制和治疗策略的理解,在彻底改变个性化医疗方面具有巨大潜力。基于人工智能的算法可以进行优化,以分析大规模、多样化的数据集,包括基因信息,通过整合和检查众多数据源,人工智能可以发现传统分析技术会遗漏的模式、相关性和见解。人工智能算法用于解读复杂的基因组数据,如DNA测序结果,以识别与疾病易感性、药物反应和治疗结果相关的基因变异。本章旨在分析针对各种基因设计的基于人工智能的药物开发现状,以及伴随的问题和充分利用人工智能在个性化医疗中所具有潜力的措施。

相似文献

1
AI-Based Drug Discovery and Design for Different Genetic Designs.基于人工智能的针对不同基因设计的药物发现与设计
Methods Mol Biol. 2025;2952:125-148. doi: 10.1007/978-1-0716-4690-8_8.
2
AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.人工智能驱动的抗菌肽发现:挖掘与生成
Acc Chem Res. 2025 Jun 17;58(12):1831-1846. doi: 10.1021/acs.accounts.0c00594. Epub 2025 Jun 3.
3
AI Revolutionizing Cell and Genetic Engineering: Innovations and Applications.人工智能革新细胞与基因工程:创新与应用
Methods Mol Biol. 2025;2952:219-232. doi: 10.1007/978-1-0716-4690-8_12.
4
The Use of AI for Phenotype-Genotype Mapping.人工智能在表型-基因型映射中的应用。
Methods Mol Biol. 2025;2952:369-410. doi: 10.1007/978-1-0716-4690-8_21.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
The impact of artificial intelligence on the endoscopic assessment of inflammatory bowel disease-related neoplasia.人工智能对炎症性肠病相关肿瘤内镜评估的影响。
Therap Adv Gastroenterol. 2025 Jun 23;18:17562848251348574. doi: 10.1177/17562848251348574. eCollection 2025.
8
Integrating Genetic Insights and Artificial Intelligence for Enhanced Oral and Maxillofacial Cancer Care.整合基因见解与人工智能以加强口腔颌面癌护理。
Methods Mol Biol. 2025;2952:107-124. doi: 10.1007/978-1-0716-4690-8_7.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.

本文引用的文献

1
Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review.当前人工智能药物发现中解决数据稀缺问题的策略:全面综述。
Comput Biol Med. 2024 Sep;179:108734. doi: 10.1016/j.compbiomed.2024.108734. Epub 2024 Jul 3.
2
A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology.多组学数据整合的机器学习技术综合综述:精准肿瘤学中的挑战与应用
Brief Funct Genomics. 2024 Sep 27;23(5):549-560. doi: 10.1093/bfgp/elae013.
3
Insights into artificial intelligence utilisation in drug discovery.
J Med Econ. 2024 Jan-Dec;27(1):304-308. doi: 10.1080/13696998.2024.2315864. Epub 2024 Feb 22.
4
Preimplantation genetic testing in the current era, a review.当前时代的植入前基因检测,一篇综述。
Arch Gynecol Obstet. 2024 May;309(5):1787-1799. doi: 10.1007/s00404-024-07370-z. Epub 2024 Feb 20.
5
Artificial intelligence for prenatal chromosome analysis.人工智能在产前染色体分析中的应用。
Clin Chim Acta. 2024 Jan 1;552:117669. doi: 10.1016/j.cca.2023.117669. Epub 2023 Nov 23.
6
Artificial Intelligence for Drug Discovery: Are We There Yet?人工智能在药物研发中的应用:我们是否已经实现?
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:527-550. doi: 10.1146/annurev-pharmtox-040323-040828. Epub 2023 Sep 22.
7
Proteogenomics in Cancer: Then and Now.癌症中的蛋白质基因组学:过去与现在。
J Proteome Res. 2023 Oct 6;22(10):3103-3122. doi: 10.1021/acs.jproteome.3c00196. Epub 2023 Sep 19.
8
The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives.人工智能/机器学习在药物发现、开发、临床测试和制造中的崭露头角:FDA 的观点。
Drug Des Devel Ther. 2023 Sep 6;17:2691-2725. doi: 10.2147/DDDT.S424991. eCollection 2023.
9
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design.制药技术与药物递送设计中的人工智能
Pharmaceutics. 2023 Jul 10;15(7):1916. doi: 10.3390/pharmaceutics15071916.
10
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies.人工智能在药物研发中的作用:挑战、机遇与策略。
Pharmaceuticals (Basel). 2023 Jun 18;16(6):891. doi: 10.3390/ph16060891.